ribavirin has been researched along with 4'-azidocytidine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coelmont, L; Dumont, JM; Kaptein, S; Neyts, J; Paeshuyse, J; Vliegen, I; Vuagniaux, G | 1 |
| Boguszewska-Chachulska, AM; Dörner, B; Erker, T; Stankiewicz-Drogoń, A | 1 |
| Boguszewska-Chachulska, AM; Bretner, M; Krawczyk, M; Najda-Bernatowicz, A; Stankiewicz-Drogoń, A | 1 |
| Chan, A; Everson, GT; Fried, MW; Ghalib, R; Godofsky, E; Harrison, S; Hill, G; Najera, I; Nelson, D; Nyberg, L; Pockros, PJ; Rodriguez-Torres, M; Shiffman, ML | 1 |
| Kronenberger, B; Zeuzem, S | 1 |
1 review(s) available for ribavirin and 4'-azidocytidine
| Article | Year |
|---|---|
Future treatment options for HCV: double, triple, what is the optimal combination?
Topics: Antiviral Agents; Cytidine; DNA-Directed RNA Polymerases; Drug Delivery Systems; Drug Resistance, Viral; Drug Therapy, Combination; Forecasting; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Nucleosides; Oligopeptides; Polyethylene Glycols; Prodrugs; Proline; Protease Inhibitors; Pyrimidine Nucleosides; Recombinant Proteins; Ribavirin | 2008 |
1 trial(s) available for ribavirin and 4'-azidocytidine
| Article | Year |
|---|---|
R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Cytidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Female; Hepacivirus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Nucleosides; Polyethylene Glycols; Prodrugs; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2008 |
3 other study(ies) available for ribavirin and 4'-azidocytidine
| Article | Year |
|---|---|
Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors.
Topics: Antiviral Agents; Clinical Trials as Topic; Cyclophilins; Cyclosporine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Hepacivirus; Hepatitis C; Humans; Replicon; Ribavirin; Viral Nonstructural Proteins | 2009 |
Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.
Topics: Acridones; Antiviral Agents; Cell Line, Tumor; Drug Resistance, Viral; Hepacivirus; Humans; Models, Molecular; Mutation; Replicon; RNA Helicases; RNA, Viral; Structure-Activity Relationship; Viral Nonstructural Proteins; Virus Replication | 2010 |
Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
Topics: Antiviral Agents; Cell Line, Tumor; DNA Helicases; Drug Synergism; Hepacivirus; Hepatitis C; Humans; Interferon-gamma; Models, Molecular; Mutation; Ribavirin; RNA Helicases; RNA, Viral; Tropolone; Viral Nonstructural Proteins; Virus Replication | 2010 |